What is ENSC's dilution risk score?

ENSC has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ENSC, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ENSC?

DilutionWatch tracks 25 SEC filing types for ENSC including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ENSC shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ENSC, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ENSC tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ENSC. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ENSC Dilution Risk Score: 65/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

95

📊 Float Risk

22

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 53%

🔄 Reverse Split model est. 70%

• 50-day avg $0.43 below $1 exchange minimum

• Only 1 months cash — financial pressure

💰 Capital Raise model 55%

• Critical: only 0.7 months cash remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (65/100)

🔔 Track ENSC — Get forecast alerts →

Market Data

Market Cap$4.13M

Shares Outstanding19.46M

Float14.68M

Cash$676.7K

Debt$245.8K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)

15 institutional holders · 586.5K shares

#1 PERCEPTIVE ADVISORS LLC 173.3K shares

#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 149.7K shares

#3 GEODE CAPITAL MANAGEMENT, LLC 73.9K shares

+ 12 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest191.3K

Days to Cover1.0

% of Float1.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-04-23

xbrl XBRL CONVERTIBLE 2026-04-06

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ENSC Dilution Snapshot

Ensysce Biosciences, Inc. (ENSC) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 880,000.
Recent SEC activity tracked for ENSC: xbrl on 2026-04-23; xbrl on 2026-04-06.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.